trivalent influenza virus split vaccine MDCK cell

**Trivalent influenza virus split vaccine MDCK cell** is an investigational, inactivated split-virion seasonal influenza vaccine manufactured using Madin-Darby canine kidney cells. It is being developed by Chengdu Olin Biotechnology, Lanzhou Bailing Biotechnology, and Chengdu Xin Nuoming Biotechnology for prevention of influenza caused by vaccine-covered influenza-virus types. The registered Phase I study evaluates safety and preliminary immunogenicity in people aged 6 months and older. The specific seasonal strains, antigen quantities, adjuvant status, presentation, and administration route were not identified in the available public trial information. ([yscro.com](https://www.yscro.com/index.php/cde/917e8532c8f0242407785a4eba733522.html))

Other names

trivalent influenza vaccine MDCK celltrivalent influenza vaccine split virion inactivated MDCK cell三价流感病毒裂解疫苗 MDCK细胞